Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4401
LiveOne
LVO
$57.2M
| $108K | ﹤0.01% |
2,963
+1,880
| +174% | +$52.5K |
|
4402
CALL
Warner Bros
WBD
$65.1B
| $108K | ﹤0.01% |
5,100
| – | – |
|
4403
XBiotech
XBIT
$68.9M
| $108K | ﹤0.01% |
7,895
+2,636
| +50% | +$37K |
|
|
MSON
4404
DELISTED
Misonix Inc
MSON
| $108K | ﹤0.01% |
7,959
+4,976
| +167% | +$60.8K |
|
|
HUD
4405
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $108K | ﹤0.01% |
22,116
+8,910
| +67% | +$46.5K |
|
4406
CALL
Alkermes
ALKS
$8.32B
| $107K | ﹤0.01% |
5,500
-3,000
| -35% | -$48.7K |
|
4407
Teucrium Corn Fund
CORN
$168M
| $107K | ﹤0.01% |
8,607
-3,638
| -30% | -$44.2K |
|
4408
LCNB Corp
LCNB
$281M
| $107K | ﹤0.01% |
6,772
+2,728
| +67% | +$37.6K |
|
|
NVO
4409
Novo Nordisk
NVO
$197B
| $107K | ﹤0.01% |
3,290
-37,134
| -92% | -$1.18M |
|
|
SA
4410
PUT
Seabridge Gold
SA
$3.14B
| $107K | ﹤0.01% |
6,100
-17,900
| -75% | -$253K |
|
|
OTIC
4411
DELISTED
Otonomy, Inc.
OTIC
| $107K | ﹤0.01% |
29,627
-4
| -0% | -$10 |
|
4412
Acacia Research
ACTG
$439M
| $106K | ﹤0.01% |
26,282
+10,638
| +68% | +$30.8K |
|
4413
ADMA Biologics
ADMA
$2.15B
| $106K | ﹤0.01% |
36,027
+12,727
| +55% | +$36.6K |
|
4414
International Money Express
IMXI
$370M
| $106K | ﹤0.01% |
8,531
+2,542
| +42% | +$25.9K |
|
|
ENDP
4415
PUT
DELISTED
Endo International plc
ENDP
| $106K | ﹤0.01% |
30,900
-10,900
| -26% | -$41.7K |
|
4416
Business First Bancshares
BFST
$1.04B
| $105K | ﹤0.01% |
6,800
+2,662
| +64% | +$36K |
|
4417
Peabody Energy
BTU
$2.78B
| $105K | ﹤0.01% |
36,682
+14,620
| +66% | +$48.3K |
|
4418
Caledonia Mining Corp
CMCL
$400M
| $105K | ﹤0.01% |
+6,101
| New | +$84.9K |
|
4419
Digimarc Corp
DMRC
$167M
| $105K | ﹤0.01% |
6,559
+2,642
| +67% | +$42.4K |
|
4420
PUT
Eagle Materials
EXP
$6.7B
| $105K | ﹤0.01% |
1,500
-300
| -17% | -$18.9K |
|
4421
IES Holdings
IESC
$15.6B
| $105K | ﹤0.01% |
4,492
+1,763
| +65% | +$36.9K |
|
4422
CALL
ProShares VIX Short-Term Futures ETF
VIXY
$185M
| $105K | ﹤0.01% |
48
-218
| -82% | -$538K |
|
|
ITI
4423
DELISTED
Iteris, Inc.
ITI
| $105K | ﹤0.01% |
22,123
+8,791
| +66% | +$36.7K |
|
|
KDNY
4424
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $105K | ﹤0.01% |
9,143
+4,772
| +109% | +$65.8K |
|
4425
PUT
Eastman Chemical
EMN
$8.39B
| $104K | ﹤0.01% |
1,500
-7,100
| -83% | -$447K |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.